Drug intelligence / Profile preview

carboxymethylcellulose + nepafenac + tobramycin + dexamethasone + tropicamide

Development stage: Unknown
Lead developer: Novartis
Modality: Small Molecules
Administration: Ophthalmic

Overview

A combination ophthalmic medication containing five active ingredients: carboxymethylcellulose (an eye lubricant), nepafenac (an NSAID), tobramycin (an aminoglycoside antibiotic), dexamethasone (a corticosteroid), and tropicamide (a mydriatic agent). This combination likely provides multiple therapeutic effects including lubrication for dry eyes, anti-inflammatory action, antibacterial protection, pain relief, and pupil dilation.

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)mAChR (Muscarinic acetylcholine receptors)23S rRNA (23S ribosomal RNA)30S A-site (Bacterial ribosomal 30S A-site)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on carboxymethylcellulose + nepafenac + tobramycin + dexamethasone + tropicamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxymethylcellulose + nepafenac + tobramycin + dexamethasone + tropicamide.

Explore the full profile